Dr. med. Aurelius Omlin
Medizinische Onkologie und Hämatologie · Dept. I
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
James N, O'Sullivan J, Omlin A, Nikapota A, Lydon A, Gibbs S, Gale J, Capaldi L, Birtle A, Beesley S, Brown J, Parikh O, Protheroe A, Rudman S, Parmar M, Sydes M, Zarkar A, Wylie J, Wallace J, Wagstaff J, Tolan S, Tanguay J, Simms M, Srihari N, Russell J, Rush H, Cross W, Cook A, Chowdhury S, Calvert J, Brawley C, Attard G, Amos C, Hoyle A, Ingleby F, Ali A, Dearnaley D, Douis H, Gilbert D, Ritchie A, Parker C, Millman R, Matheson D, Mason M, Malik Z, MacNair A, Langley R, Jones R, Gillessen S, Clarke N. Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. Ann Oncol 2019
27.09.2019Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
27.09.2019Ann Oncol 2019
James N D, O'Sullivan J M, Omlin Aurelius, Nikapota A, Lydon A, Gibbs S, Gale J, Capaldi L, Birtle A, Beesley S, Brown J, Parikh O, Protheroe A, Rudman S, Parmar M K B, Sydes M R, Zarkar A, Wylie J, Wallace J, Wagstaff J, Tolan S, Tanguay J S, Simms M, Srihari N N, Russell J M, Rush H, Cross W, Cook A, Chowdhury S, Calvert J, Brawley C D, Attard G, Amos C L, Hoyle A, Ingleby F C, Ali A, Dearnaley D P, Douis H, Gilbert D, Ritchie A W S, Parker C C, Millman R, Matheson D, Mason M D, Malik Z, MacNair A, Langley R E, Jones R J, Gillessen S, Clarke N W
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Rescigno P, Romero-Laorden N, Castro E, Saez M, Mehra N, Smeenk S, Sideris S, Gil T, Banks P, Sandhu S, Sternberg C, De Giorgi U, Olmos D, Morley C, Pezaro C, Dolling D, Conteduca V, Rediti M, Bianchini D, Lolli C, Ong M, Li H, Omlin A, Schmid S, Caffo O, Zivi A, de Bono J. Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis. Eur Urol Oncol 2019
12.07.2019Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
12.07.2019Eur Urol Oncol 2019
Rescigno Pasquale, Romero-Laorden Nuria, Castro Elena, Saez Maria I, Mehra Niven, Smeenk Stella, Sideris Spyridon, Gil Thyerry, Banks Patricia, Sandhu Shaneen K, Sternberg Cora N, De Giorgi Ugo, Olmos David, Morley Courtney, Pezaro Carmel J, Dolling David, Conteduca Vincenza, Rediti Mattia, Bianchini Diletta, Lolli Cristian, Ong Michael, Li Haoran, Omlin Aurelius, Schmid Sabine, Caffo Orazio, Zivi Andrea, de Bono Johann S
Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations
Mukherji D, Hussain H, Sayyid K, Ibrahim K, Haidar M, Zouain N, Bitar N, Alameh W, Abbas F, Faddoul S, Nemer E, Assaf G, Farhat F, Bulbul M, Temraz S, Shamseddine A, Gillessen Sommer S, Omlin A, Sakr G, El Khoury C, Youssef B, Dagher C, El-Hajj A, Nasr R, Geara F, Rabah D, Al Dousari S, Said R, Ashou R, Wazzan W, Jabbour M, Farha G, Al Hamdani N, Al Hallaq Y, Ghazal H, Dbouk H, Bachir B, Khauli R. Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations. World J Urol 2019
11.07.2019Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations
11.07.2019World J Urol 2019
Mukherji Deborah, Hussain Hero K, Sayyid Khaled, Ibrahim Khaled, Haidar Mohammad, Zouain Nicolas, Bitar Nizar, Alameh Walid, Abbas Fadi, Faddoul Sami, Nemer Elie, Assaf Georges, Farhat Fadi, Bulbul Muhammad, Temraz Sally, Shamseddine Ali, Gillessen Sommer Silke, Omlin Aurelius, Sakr Ghazi, El Khoury Clement, Youssef Bassem, Dagher Christelle, El-Hajj Albert, Nasr Rami, Geara Fadi, Rabah Danny, Al Dousari Saad, Said Rabih, Ashou Raja, Wazzan Wassim, Jabbour Michel, Farha George, Al Hamdani Nibras, Al Hallaq Yousuf, Ghazal Hassan, Dbouk Haifa, Bachir Bassel, Khauli Raja
Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art
Pérez-López R, de Bono J, Morris M, Omlin A, Vargas H, Fanti S, Oyen W, Padhani A, Tunariu N, Koh D. Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art. Radiology 2019; 292:273-286.
25.06.2019Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art
25.06.2019Radiology 2019; 292:273-286
Pérez-López Raquel, de Bono Johann, Morris Michael J, Omlin Aurelius, Vargas Hebert Alberto, Fanti Stefano, Oyen Wim J G, Padhani Anwar R, Tunariu Nina, Koh Dow-Mu
Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic Model
Betschart P, Schmid H, Klingbiel D, Engeler D, Gillessen Sommer S, Schwab C, Abt D, Rothermundt C, Schmid S, Babst C, Omlin A. Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic Model. Oncol Res Treat 2019; 42:366-374.
06.06.2019Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic Model
06.06.2019Oncol Res Treat 2019; 42:366-374
Betschart Patrick, Schmid Hans-Peter, Klingbiel Dirk, Engeler Daniel, Gillessen Sommer Silke, Schwab Christoph, Abt Dominik, Rothermundt Christian, Schmid Sabine, Babst Christa, Omlin Aurelius
The Advanced Prostate Cancer Consensus on a regional level - what can we learn?
Omlin A, Gillessen Sommer S. The Advanced Prostate Cancer Consensus on a regional level - what can we learn?. BJU Int 2019; 123:3-4.
01.01.2019The Advanced Prostate Cancer Consensus on a regional level - what can we learn?
01.01.2019BJU Int 2019; 123:3-4
Omlin Aurelius, Gillessen Sommer Silke
Seminal vesicle sparing robotic radical prostatectomy - no different interpretation of postoperative PSA follow-up required?
Betschart P, Omlin A, Abt D. Seminal vesicle sparing robotic radical prostatectomy - no different interpretation of postoperative PSA follow-up required?. Swiss Med Wkly 2018; 148:w14698.
15.12.2018Seminal vesicle sparing robotic radical prostatectomy - no different interpretation of postoperative PSA follow-up required?
15.12.2018Swiss Med Wkly 2018; 148:w14698
Betschart Patrick, Omlin Aurelius, Abt Dominik
Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
Müller J, von Schulthess G, Kaufmann P, Kranzbuehler H, John H, Zilli T, Müller A, Omlin A, Schmid D, Sulser T, Kroeze S, Guckenberger M, Eberli D, Kedzia S, Garcia Schüler H, Muehlematter U, Ferraro D, Burger I. Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction. Eur J Nucl Med Mol Imaging 2018
28.11.2018Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
28.11.2018Eur J Nucl Med Mol Imaging 2018
Müller Julian, von Schulthess Gustav K, Kaufmann Philipp A, Kranzbuehler Helmut, John Hubert, Zilli Thomas, Müller Alexander, Omlin Aurelius, Schmid Daniel M, Sulser Tullio, Kroeze Stephanie G C, Guckenberger Matthias, Eberli Daniel, Kedzia Sarah, Garcia Schüler Helena I, Muehlematter Urs J, Ferraro Daniela A, Burger Irene A
[Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]
Omlin A, Zwahlen D, Wyler S, Wild D, Templeton A, Stenner F, Schmid H, Roggero E, Rentsch C, Nitzsche E, Kueng M, Jochum W, Gillessen Sommer S, Eberli D, Beyer J, Spahn M, Cathomas R. [Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]. Praxis (Bern 1994) 2018; 107:1043-1051.
01.09.2018[Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]
01.09.2018Praxis (Bern 1994) 2018; 107:1043-1051
Omlin Aurelius, Zwahlen Daniel, Wyler Stephen, Wild Damian, Templeton Arnoud J, Stenner Frank, Schmid Hans-Peter, Roggero Enrico, Rentsch Cyrill A, Nitzsche Egbert, Kueng Marc, Jochum Wolfram, Gillessen Sommer Silke, Eberli Daniel, Beyer Jörg, Spahn Martin, Cathomas Richard
Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS
Sajic T, Claassen M, Gillessen Sommer S, Omlin A, Malander S, Niméus E, Friedrich B, Blattmann P, Chen R, Brentnall T, Pan S, Sethi A, Hüttenhain R, Schiess R, Williams E, Surinova S, Arvaniti E, Liu Y, Aebersold R. Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS. Cell Rep 2018; 23:2819-2831.e5.
29.05.2018Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS
29.05.2018Cell Rep 2018; 23:2819-2831.e5
Sajic Tatjana, Claassen Manfred, Gillessen Sommer Silke, Omlin Aurelius, Malander Susanne, Niméus Emma, Friedrich Betty, Blattmann Peter, Chen Ru, Brentnall Teresa A, Pan Sheng, Sethi Atul, Hüttenhain Ruth, Schiess Ralph, Williams Evan G, Surinova Silvia, Arvaniti Eirini, Liu Yansheng, Aebersold Ruedi
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
Sumanasuriya S, Luo J, Mehra N, Olmos D, Scher H, Soule H, Stoecklein N, Terstappen L, Waugh D, Lorente D, Lolkema M, Omlin A, Armstrong A, Attard G, Chi K, Bevan C, Shibakawa A, IJzerman M, De Laere B, de Bono J. Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer. Eur Urol Oncol 2018; 1:151-159.
15.05.2018Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
15.05.2018Eur Urol Oncol 2018; 1:151-159
Sumanasuriya Semini, Luo Jun, Mehra Niven, Olmos David, Scher Howard, Soule Howard, Stoecklein Nikolas H, Terstappen Leon W M M, Waugh David, Lorente David, Lolkema Martijn, Omlin Aurelius, Armstrong Andrew, Attard Gerhardt, Chi Kim N, Bevan Charlotte L, Shibakawa Aki, IJzerman Maarten J, De Laere Bram, de Bono Johann S
Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer
Gong J, Omlin A, Pal S, Hsu J, Tombal B, Sydes M, Gillessen Sommer S. Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer. Eur Urol 2018
03.05.2018Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer
03.05.2018Eur Urol 2018
Gong Jun, Omlin Aurelius, Pal Sumanta K, Hsu J, Tombal Bertrand, Sydes Matthew R, Gillessen Sommer Silke
Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?
Isensee G, Péporté A, Müller J, Schmid S, Gillessen Sommer S, Omlin A. Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?. Clin Genitourin Cancer 2018; 16:349-354.
23.04.2018Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?
23.04.2018Clin Genitourin Cancer 2018; 16:349-354
Isensee Gesa, Péporté Anne, Müller Joachim, Schmid Sabine, Gillessen Sommer Silke, Omlin Aurelius
Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study
Gordon J, Cox M, De Placido P, Ribera D, Omlin A, Buonocore G, Chi K, Kollmannsberger C, Khalaf D, Facchini G, Sonpavde G, De Placido S, Eigl B, Cherhroudi C, Pignata S, Battaglia M, Buonerba C, Pond G, Crona D, Gillessen Sommer S, Lucarelli G, Rossetti S, Dorff T, Artale S, Locke J, Bosso D, Milowsky M, Witek M, Di Lorenzo G. Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study. Oncotarget 2018; 9:19861-19873.
13.04.2018Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study
13.04.2018Oncotarget 2018; 9:19861-19873
Gordon Jacob A, Cox Michael E, De Placido Pietro, Ribera Dario, Omlin Aurelius, Buonocore Gaetano, Chi Kim, Kollmannsberger Christian, Khalaf Daniel, Facchini Gaetano, Sonpavde Guru, De Placido Sabino, Eigl Bernhard J, Cherhroudi Cyrus, Pignata Sandro, Battaglia Michele, Buonerba Carlo, Pond Gregory, Crona Daniel, Gillessen Sommer Silke, Lucarelli Giuseppe, Rossetti Sabrina, Dorff Tanya, Artale Salvatore, Locke Jennifer A, Bosso Davide, Milowsky Matthew Ivan, Witek Mira Sofie, Di Lorenzo Giuseppe
When and how to use carboplatin in metastatic castration-resistant prostate cancer?
Omlin A, Gillessen Sommer S. When and how to use carboplatin in metastatic castration-resistant prostate cancer?. Eur J Cancer 2018; 92:96-99.
31.01.2018When and how to use carboplatin in metastatic castration-resistant prostate cancer?
31.01.2018Eur J Cancer 2018; 92:96-99
Omlin Aurelius, Gillessen Sommer Silke
Prostatakarzinom im Alter. Diagnostik und Therapie bei Betagten
Viktorin P, Omlin A, Schmid H. Prostatakarzinom im Alter. Diagnostik und Therapie bei Betagten. info@onkologie 2018; 8:5-8.
01.01.2018Prostatakarzinom im Alter. Diagnostik und Therapie bei Betagten
01.01.2018info@onkologie 2018; 8:5-8
Viktorin P, Omlin Aurelius, Schmid Hans-Peter
Behandlung des fortgeschrittenen Prostatakarzinoms - eine interdisziplinäre Empfehlung
Omlin A, Zwahlen D, Wyler S, Wild D, Templeton A, Stenner F, Schmid H, Roggero E, Rentsch C, Nitzsche E, Kueng M, Jochum W, Gillessen Sommer S, Eberli D, Beyer J, Spahn M, Cathomas R. Behandlung des fortgeschrittenen Prostatakarzinoms - eine interdisziplinäre Empfehlung. Schweiz Rundschau Med (PRAXIS) 2018; 107:1043-51.
01.01.2018Behandlung des fortgeschrittenen Prostatakarzinoms - eine interdisziplinäre Empfehlung
01.01.2018Schweiz Rundschau Med (PRAXIS) 2018; 107:1043-51
Omlin Aurelius, Zwahlen D, Wyler S, Wild D, Templeton Arnoud, Stenner F, Schmid Hans-Peter, Roggero E, Rentsch CA, Nitzsche E, Kueng M, Jochum W, Gillessen Sommer Silke, Eberli D, Beyer J, Spahn M, Cathomas R
Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
Fankhauser C, Moch H, Sulser T, Poyet C, Hermanns T, Rueschoff J, Rupp N, Omlin A, Gillessen Sommer S, Schüffler P, Wild P. Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer. Oncotarget 2017; 9:10284-10293.
04.12.2017Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
04.12.2017Oncotarget 2017; 9:10284-10293
Fankhauser Christian D, Moch Holger, Sulser Tullio, Poyet Cédric, Hermanns Thomas, Rueschoff Jan H, Rupp Niels J, Omlin Aurelius, Gillessen Sommer Silke, Schüffler Peter J, Wild Peter J
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer
Heinrich D, van Oort I, Tucci M, Sridhar S, Omlin A, Olmos D, Kramer G, Kindblom J, Keizman D, Daugaard G, Chi K, Cathomas R, Caffo O, Bergman A, Bektic J, Nilsson S. The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer. Clin Genitourin Cancer 2017
06.09.2017The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer
06.09.2017Clin Genitourin Cancer 2017
Heinrich Daniel, van Oort Inge, Tucci Marcello, Sridhar Srikala S, Omlin Aurelius, Olmos David, Kramer Gero, Kindblom Jon, Keizman Daniel, Daugaard Gedske, Chi Kim N, Cathomas Richard, Caffo Orazio, Bergman Andries M, Bektic Jasmin, Nilsson Sten
Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.06.002
Gillessen Sommer S, de Bono J, Sartor O, Omlin A. Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.06.002. Eur Urol 2017
28.08.2017Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.06.002
28.08.2017Eur Urol 2017
Gillessen Sommer Silke, de Bono Johann S, Sartor Oliver, Omlin Aurelius